Role of Vasodilator Therapy in Acute Heart Failure.

acute heart failure heart failure hfref management mortality vasodilator therapy

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2021
Historique:
accepted: 27 06 2021
entrez: 17 9 2021
pubmed: 18 9 2021
medline: 18 9 2021
Statut: epublish

Résumé

Over the past decade, several trials have questioned the efficacy of vasodilator therapy in acute heart failure (AHF) in the absence of uncontrolled hypertension. In this article, we provide a unique review of the most valuable four trials that present the role of vasodilator therapy in the management of patients with AHF. These four trials have evaluated the efficacy of different types of vasodilators such as nesiritide, ulatritide, and serelaxin in the setting of AHF. Also, we compared comprehensive vasodilator therapy versus standard therapy to see if there is any effect on mortality and re-hospitalization.

Identifiants

pubmed: 34532168
doi: 10.7759/cureus.17126
pmc: PMC8434813
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e17126

Informations de copyright

Copyright © 2021, Batool et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Am Coll Cardiol. 2006 Jan 3;47(1):76-84
pubmed: 16386668
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Am Coll Cardiol. 2019 Oct 15;74(15):1966-2011
pubmed: 31526538
Eur J Heart Fail. 2017 Jul;19(7):821-836
pubmed: 28560717
J Card Fail. 2016 Nov;22(11):875-883
pubmed: 27133201
JAMA. 2005 Apr 20;293(15):1900-5
pubmed: 15840865
JAMA. 2002 Mar 27;287(12):1531-40
pubmed: 11911755
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Circulation. 2005 Mar 29;111(12):1487-91
pubmed: 15781736
N Engl J Med. 2000 Jul 27;343(4):246-53
pubmed: 10911006
N Engl J Med. 2017 Nov 16;377(20):1964-1975
pubmed: 29141174
Lancet. 2013 Jan 5;381(9860):29-39
pubmed: 23141816
Maedica (Bucur). 2016 Dec;11(4):320-324
pubmed: 28828050
Heart. 2007 Sep;93(9):1137-46
pubmed: 17699180
Cardiol Clin. 2014 Feb;32(1):9-19, vii
pubmed: 24286575
N Engl J Med. 2017 May 18;376(20):1956-1964
pubmed: 28402745
Heart. 2015 Dec;101(23):1861-7
pubmed: 26123135
N Engl J Med. 2019 Aug 22;381(8):716-726
pubmed: 31433919
Ann Emerg Med. 2007 Aug;50(2):144-52
pubmed: 17509731
JAMA. 2019 Dec 17;322(23):2292-2302
pubmed: 31846016
Lancet. 1998 Feb 7;351(9100):389-93
pubmed: 9482291
N Engl J Med. 2011 Jul 7;365(1):32-43
pubmed: 21732835
Front Physiol. 2019 May 29;10:638
pubmed: 31191343

Auteurs

Aisha Batool (A)

Internal Medicine, Columbia St. Mary Hospital, Milwaukee, USA.

Negar Salehi (N)

Cardiology, University of Arkansas for Medical Sciences, Little Rock, USA.

Shahzad Chaudhry (S)

Family Medicine, Aurora Health Center, Greenfield, USA.

Michael Cross (M)

Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.

Abdallah Malkawi (A)

Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.

Aisha Siraj (A)

Cardiology, MetroHealth Medical Center, Cleveland, USA.

Classifications MeSH